Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 7
Submit an article Journal homepage
1,553
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response

Joana FelixINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France
,
Jérome LambertUniversité Paris Diderot, Sorbonne Paris Cité, Paris, France;AP-HP, Hôpital Saint-Louis, Service de Biostatistique et Informatique Médicale, Paris, France;INSERM, UMR 1153, Center de Recherche Epidémiologie et Statistique (CRESS), Paris, France
,
Marie RoelensINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France
,
Eve MaubecService de Dermatologie, Hôpital Xavier Bichat, AP-HP, Paris, France
,
Hélène GuermoucheINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France
,
Cécile PagesService de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France
,
Irina SidinaService de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France
,
Debora J. CordeiroINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France
,
Guitta MakiLaboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, France
,
François ChassetService de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France
,
Raphaël PorcherINSERM, UMR 1153, Center de Recherche Epidémiologie et Statistique (CRESS), Paris, France;Centre d'Epidémiologie Clinique, Hôtel-Dieu, AP-HP, Paris, France;Université Paris Descartes, Sorbonne Paris Cité, Paris, France
,
Martine BagotUniversité Paris Diderot, Sorbonne Paris Cité, Paris, France;Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France;INSERM, UMR-976, Hôpital Saint-Louis, Paris, France
,
Anne CaignardINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France
,
Antoine ToubertINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, FranceCorrespondence[email protected]
,
Céleste LebbéUniversité Paris Diderot, Sorbonne Paris Cité, Paris, France;Service de Dermatologie, AP-HP, Hôpital Saint Louis, Paris, France;INSERM, UMR-976, Hôpital Saint-Louis, Paris, FranceCorrespondence[email protected]
&
Hélène Moins-TeisserencINSERM, UMR-1160, Institut Universitaire d'Hématologie, Paris, France;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;Laboratoire d'Immunologie-Histocompatibilité, AP-HP, Hôpital Saint Louis, Paris, FranceCorrespondence[email protected]
 show all
Article: 1136045 | Received 07 Oct 2015, Accepted 18 Dec 2015, Published online: 11 Jul 2016

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Carole Fournier, François Martin, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Lionel Apetoh. (2017) Trial Watch: Adoptively transferred cells for anticancer immunotherapy. OncoImmunology 6:11.
Read now
Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Dendritic cell-based anticancer immunotherapy. OncoImmunology 6:7.
Read now

Articles from other publishers (18)

Livius Penter, Yang Liu, Jacquelyn O. Wolff, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Nicole M. Cullen, Kathleen L. Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Elizabeth A. Morgan, Helen X. Chen, Minkyung H. Song, Magdalena Thurin, Shuqiang Li, Scott J. Rodig, Carrie Cibulskis, Stacey Gabriel, Pavan Bachireddy, Jerome Ritz, Howard Streicher, Donna S. Neuberg, F. Stephen Hodi, Matthew S. Davids, Sacha Gnjatic, Kenneth J. Livak, Jennifer Altreuter, Franziska Michor, Robert J. Soiffer, Jacqueline S. Garcia & Catherine J. Wu. (2023) Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease. Blood 141:15, pages 1817-1830.
Crossref
Tetje C. van der Sluis, Guillaume Beyrend, Esmé T.I. van der Gracht, Tamim Abdelaal, Simon P. Jochems, Robert A. Belderbos, Thomas H. Wesselink, Suzanne van Duikeren, Floortje J. van Haften, Anke Redeker, Laura F. Ouboter, Elham Beyranvand Nejad, Marcel Camps, Kees L.M.C. Franken, Margot M. Linssen, Peter Hohenstein, Noel F.C.C. de Miranda, Hailiang Mei, Adriaan D. Bins, John B.A.G. Haanen, Joachim G. Aerts, Ferry Ossendorp & Ramon Arens. (2023) OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum. Cell Reports Medicine 4:3, pages 100939.
Crossref
Allan Relecom, Maysaloun Merhi, Varghese Inchakalody, Shahab Uddin, Darawan Rinchai, Davide Bedognetti & Said Dermime. (2021) Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Cara Haymaker, Daniel H. Johnson, Ravi Murthy, Salah-Eddine Bentebibel, Marc I. Uemura, Courtney W. Hudgens, Houssein Safa, Marihella James, Robert H.I. Andtbacka, Douglas B. Johnson, Montaser Shaheen, Michael A. Davies, Shah Rahimian, Srinivas K. Chunduru, Denái R. Milton, Michael T. Tetzlaff, Willem W. Overwijk, Patrick Hwu, Nashat Gabrail, Sudhir Agrawal, Gary Doolittle, Igor Puzanov, Joseph Markowitz, Chantale Bernatchez & Adi Diab. (2021) Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma. Cancer Discovery 11:8, pages 1996-2013.
Crossref
Afsheen Raza, Maysaloun Merhi, Allan Relecom, Queenie Fernandes, Varghese Inchakalody, Abdul Rahman Zar Gul, Shahab Uddin, Mohammed Ussama Al Homsi & Said Dermime. 2021. Advances in Precision Medicine Oncology. Advances in Precision Medicine Oncology.
Livius Penter, Yi Zhang, Alexandra SavellTeddy Huang, Nicoletta Cieri, Emily M. Thrash, Seunghee Kim-SchulzeAashna JhaveriJingxin Fu, Srinika RanasingheShuqiang Li, Wandi ZhangEmma S. HathawayMatthew NazzaroHaesook T. KimHelen Chen, Magdalena Thurin, Scott J. Rodig, Mariano SevergniniCarrie CibulskisStacey GabrielKenneth J. Livak, Corey Cutler, Joseph H. Antin, Sarah Nikiforow, John Koreth, Vincent T. Ho, Philippe Armand, Jerome Ritz, Howard Streicher, Donna NeubergF. Stephen HodiSacha Gnjatic, Robert J. Soiffer, X. Shirley LiuMatthew S. Davids, Pavan Bachireddy & Catherine J. Wu. (2021) Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Blood 137:23, pages 3212-3217.
Crossref
Louise Rethacker, Marie Roelens, Claudia Bejar, Eve Maubec, Hélène Moins-Teisserenc & Anne Caignard. (2021) Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy. Cancers 13:6, pages 1446.
Crossref
Sreya BagchiRobert YuanEdgar G. Engleman. (2021) Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. Annual Review of Pathology: Mechanisms of Disease 16:1, pages 223-249.
Crossref
Clélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci, Julien Schmidt, Domenico Mallardo, Atmane Seck, Vahe Asvatourian, Lydie Cassard, Patrick Saulnier, Ludovic Lacroix, Paul-Louis Woerther, Aurore Vozy, Marie Naigeon, Laetitia Nebot-Bral, Mélanie Desbois, Ester Simeone, Christine Mateus, Lisa Boselli, Jonathan Grivel, Emilie Soularue, Patricia Lepage, Franck Carbonnel, Paolo Antonio Ascierto, Caroline Robert & Nathalie Chaput. (2020) Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nature Communications 11:1.
Crossref
Luca Mastracci, Vincenzo Fontana, Paola Queirolo, Roberta Carosio, Federica Grillo, Anna Morabito, Barbara Banelli, Enrica Tanda, Andrea Boutros, Beatrice Dozin, Marina Gualco, Sandra Salvi, Massimo Romani, Francesco Spagnolo, Alessandro Poggi & Maria Pia Pistillo. (2020) Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization. Cancer Immunology, Immunotherapy 69:4, pages 653-662.
Crossref
Wouter Ouwerkerk, Mirjam van den Berg, Sanne van der Niet, Jacqueline Limpens & Rosalie M. Luiten. (2019) Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review. Melanoma Research 29:5, pages 453-464.
Crossref
Amer M. Zeidan, Hanna A. Knaus, Tara M. Robinson, Andrea M.H. Towlerton, Edus H. Warren, Joshua F. Zeidner, Amanda L. Blackford, Amy S. Duffield, David Rizzieri, Mark G. Frattini, Yair M. Levy, Mark A. Schroeder, Anna Ferguson, Katherine E. Sheldon, Amy E. DeZern, Ivana Gojo, Steven D. Gore, Howard Streicher, Leo Luznik & B. Douglas Smith. (2018) A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure. Clinical Cancer Research 24:15, pages 3519-3527.
Crossref
Theresa El-Murr, Ankita Patel, Carrie Sedlak & Bernadette D'Souza-Lobo. (2018) Evaluating dendritic cells as an in vitro screening tool for immunotherapeutic formulations. Journal of Immunological Methods 459, pages 55-62.
Crossref
Kristian M. Hargadon. (2017) Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma. Frontiers in Immunology 8.
Crossref
Marie RoelensMarc DelordCaroline Ram-Wolff, Anne Marie-CardineAntonio Alberdi, Guitta MakiLaurence HomyrdaArmand Bensussan, Martine Bagot, Antoine Toubert & Hélène Moins-Teisserenc. (2017) Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity. Blood 130:12, pages 1468-1471.
Crossref
Kilian Wistuba-Hamprecht, Alexander Martens, Florian Heubach, Emanuela Romano, Marnix Geukes Foppen, Jianda Yuan, Michael Postow, Phillip Wong, Domenico Mallardo, Bastian Schilling, Anna Maria Di Giacomo, Amir Khammari, Brigitte Dreno, Michele Maio, Dirk Schadendorf, Paolo A. Ascierto, Jedd D. Wolchok, Christian U. Blank, Claus Garbe, Graham Pawelec & Benjamin Weide. (2017) Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients. European Journal of Cancer 73, pages 61-70.
Crossref
A. Prieto Martín, J. Barbarroja Escudero, A.M. Gómez Lahoza & J. Monserrat Sanz. (2017) Tráfico leucocitario y trastorno inflamatorio. Medicine - Programa de Formación Médica Continuada Acreditado 12:24, pages 1408-1417.
Crossref
Joana Felix, Bruno Cassinat, Raphael Porcher, Marie-Hélène Schlageter, Eve Maubec, Cécile Pages, Barouyr Baroudjian, Laurence Homyrda, Wahid Boukouaci, Ryad Tamouza, Martine Bagot, Anne Caignard, Antoine Toubert, Céleste Lebbé & Hélène Moins-Teisserenc. (2016) Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy. International Immunopharmacology 40, pages 466-473.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.